semaglutide cardiovascular and Outcomes in Obesity | NEJM Cardiovascular outcomes of semaglutide and

These include improvements in cardiovascular outcomes, making it particularly relevant for patients with type 2 diabetes who are at higher risk of heart disease. Such benefits have positioned semaglutide as a comprehensive metabolic therapy rather than a single-purpose drug

If you experience appetite suppression but weight loss has stalled , the medication may be working but other factors need adjustment

This helps reduce food noise, which is the constant intrusive thoughts about eating

However, choosing the pharmacy that handles your prescription is not an option

Considering the use of GLP-1 receptor agonists in women with obesity prior to pregnancy: a narrative review

Weight Loss and Variation of Levothyroxine Requirements in hypothyroid subjects after bariatric surgery